STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Compugen to Participate in Multiple Virtual Investor Conferences in April 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Compugen (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company, has announced its participation in three major virtual investor conferences in April 2025:

  • H.C. Wainwright 2nd Annual AI Based Drug Discovery & Development Conference on April 2, 2025, featuring a fireside chat at 9:30 am ET
  • 24th Annual Needham Virtual Healthcare Conference on April 7, 2025, with a fireside chat scheduled for 8:00 am ET
  • Stifel's 2025 Virtual Targeted Oncology Forum on April 9, 2025, including a fireside chat at 12:00 pm ET

All events will include fireside chats and one-on-one meetings. Live webcasts will be available on Compugen's website investor relations page, with replays accessible after the events.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

HOLON, Israel, March 26, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will participate in the following upcoming virtual investor conferences in April 2025:

H.C. Wainwright 2nd Annual AI Based Drug Discovery & Development Conference
Date: Wednesday, April 2, 2025
Format: Fireside chat and 1x1 meetings
Fireside chat time: 9:30 am ET

24th Annual Needham Virtual Healthcare Conference
Date: Monday, April 7, 2025
Format: Fireside chat and 1x1 meetings
Fireside chat time: 8:00 am ET

Stifel's 2025 Virtual Targeted Oncology Forum
Date: Wednesday, April 9, 2025
Format: Fireside chat and 1x1 meetings
Fireside chat time: 12:00 pm ET

Live webcasts of the fireside chats will be available on the events page of the Investor Relations section of Compugen's website at www.cgen.com. Replays will be available following the live events.

About Compugen 
Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery platform (UnigenTM) to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has two proprietary product candidates in Phase 1 development: COM701, a potential first-in-class anti-PVRIG antibody and COM902, a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors. Rilvegostomig, a PD-1/TIGIT bispecific antibody where the TIGIT component is derived from Compugen's clinical stage anti-TIGIT antibody, COM902, is in Phase 3 development by AstraZeneca through a license agreement for the development of bispecific and multispecific antibodies. GS-0321 (previously COM503), a potential first-in-class, high affinity anti-IL-18 binding protein antibody, which is in Phase 1 development is licensed to Gilead. In addition, the Company's therapeutic pipeline of early-stage immuno-oncology programs consists of research programs aiming to enhance anti-cancer immunity. Compugen is headquartered in Israel, with offices in San Francisco, CA. Compugen's shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN.

Company contact:
Yvonne Naughton, Ph.D.
Head of Investor Relations and Corporate Communications
Email: ir@cgen.com
Tel: +1 (628) 241-0071  

Cision View original content:https://www.prnewswire.com/news-releases/compugen-to-participate-in-multiple-virtual-investor-conferences-in-april-2025-302411894.html

SOURCE Compugen Ltd.

FAQ

Which investor conferences will Compugen (CGEN) attend in April 2025?

Compugen will participate in three conferences: H.C. Wainwright AI Based Drug Discovery Conference (April 2), Needham Virtual Healthcare Conference (April 7), and Stifel's Virtual Targeted Oncology Forum (April 9).

What is the schedule for Compugen's (CGEN) fireside chats in April 2025 conferences?

Fireside chats are scheduled for 9:30 am ET on April 2, 8:00 am ET on April 7, and 12:00 pm ET on April 9, 2025.

How can investors access Compugen's (CGEN) April 2025 conference presentations?

Live webcasts will be available on Compugen's website investor relations events page at www.cgen.com, with replays available after the events.

What types of meetings will Compugen (CGEN) offer during the April 2025 conferences?

Compugen will offer both fireside chat presentations and one-on-one meeting opportunities at all three virtual conferences.
Compugen

NASDAQ:CGEN

CGEN Rankings

CGEN Latest News

CGEN Latest SEC Filings

CGEN Stock Data

148.72M
91.64M
2.03%
16.56%
1.01%
Biotechnology
Healthcare
Link
Israel
Holon